01324-6/asset/4a54a807-9d4c-43b0-9cee-525570c8c25d/main.assets/gr2_lrg.jpg)
tirzepatide half-life 5 days 116 hours Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial Split Dosing / Standard Dosing
Description
The distinction between split dosing and five-day dosing is critical
[DOI] [PubMed] [Google Scholar] 23
Brand-name medications typically cost more than compounded alternatives, especially without insurance coverage
I look after my muscle mass via resistance exercise and good protein intake
Most side effects are mild to moderate gastrointestinal symptoms, which often improve with time
We have a structured, evidence-guided protocol for evaluating when dose reduction or full discontinuation may be appropriate and how to do it safely
